Genki Tohnai

878 total citations
21 papers, 519 citations indexed

About

Genki Tohnai is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Genki Tohnai has authored 21 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Genetics and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Genki Tohnai's work include Neurogenetic and Muscular Disorders Research (12 papers), Genetic Neurodegenerative Diseases (11 papers) and Muscle Physiology and Disorders (8 papers). Genki Tohnai is often cited by papers focused on Neurogenetic and Muscular Disorders Research (12 papers), Genetic Neurodegenerative Diseases (11 papers) and Muscle Physiology and Disorders (8 papers). Genki Tohnai collaborates with scholars based in Japan and United States. Genki Tohnai's co-authors include Gen Sobue, Masahisa Katsuno, Madoka Iida, Hiroaki Adachi, Naohide Kondo, Yu Miyazaki, Hideki Doi, Hideaki Nakatsuji, Makoto Minamiyama and Fumiaki Tanaka and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Neuroscience.

In The Last Decade

Genki Tohnai

19 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Genki Tohnai Japan 12 384 197 123 72 71 21 519
Naohide Kondo Japan 15 389 1.0× 266 1.4× 168 1.4× 111 1.5× 61 0.9× 27 578
Ina Woods Ireland 14 325 0.8× 145 0.7× 76 0.6× 145 2.0× 56 0.8× 19 547
Mariane da Cunha Jaeger Brazil 12 239 0.6× 105 0.5× 84 0.7× 58 0.8× 44 0.6× 34 429
Yilu Gao China 14 275 0.7× 89 0.5× 52 0.4× 41 0.6× 87 1.2× 34 504
Laura Cajola Italy 11 190 0.5× 133 0.7× 183 1.5× 36 0.5× 65 0.9× 15 479
Francesco P. Jori Italy 10 352 0.9× 86 0.4× 100 0.8× 35 0.5× 53 0.7× 11 529
A. Harel Israel 13 226 0.6× 241 1.2× 41 0.3× 88 1.2× 55 0.8× 22 584
Amanda M. Smith United States 10 297 0.8× 121 0.6× 43 0.3× 35 0.5× 52 0.7× 18 526
Lindsey D. Goodman United States 12 241 0.6× 66 0.3× 124 1.0× 117 1.6× 41 0.6× 24 451
Maria Dimitriadi United Kingdom 14 555 1.4× 59 0.3× 188 1.5× 103 1.4× 90 1.3× 17 857

Countries citing papers authored by Genki Tohnai

Since Specialization
Citations

This map shows the geographic impact of Genki Tohnai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genki Tohnai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genki Tohnai more than expected).

Fields of papers citing papers by Genki Tohnai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Genki Tohnai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genki Tohnai. The network helps show where Genki Tohnai may publish in the future.

Co-authorship network of co-authors of Genki Tohnai

This figure shows the co-authorship network connecting the top 25 collaborators of Genki Tohnai. A scholar is included among the top collaborators of Genki Tohnai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Genki Tohnai. Genki Tohnai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Yuta, Yu Kawakami, Takashi Yoshimura, et al.. (2025). The TDP-43I383V heterozygous mutation results in increased TDP-43 expression and altered neuronal activity in ALS patient-derived iPSC motor neurons. Neuroscience Research. 222. 105003–105003.
2.
Ishihara, Tomohiko, Akihide Koyama, Masashi Aoki, et al.. (2024). SMN2 gene copy number affects the incidence and prognosis of motor neuron diseases in Japan. BMC Medical Genomics. 17(1). 263–263. 1 indexed citations
3.
Nakatsuji, Hideaki, Kentaro Sahashi, Madoka Iida, et al.. (2023). Exercise attenuates polyglutamine‐mediated neuromuscular degeneration in a mouse model of spinal and bulbar muscular atrophy. Journal of Cachexia Sarcopenia and Muscle. 15(1). 159–172. 4 indexed citations
4.
Yokoi, Satoshi, Kentaro Sahashi, Masahiro Nakatochi, et al.. (2022). TheSYNGAP13′UTR Variant in ALS Patients Causes AberrantSYNGAP1Splicing and Dendritic Spine Loss by Recruiting HNRNPK. Journal of Neuroscience. 42(47). 8881–8896. 4 indexed citations
5.
Sahashi, Kentaro, Kiyoshi Tachikawa, Michelle Nguyen, et al.. (2021). Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS. Molecular Therapy — Nucleic Acids. 24. 1–10. 27 indexed citations
6.
Iida, Madoka, Kentaro Sahashi, Naohide Kondo, et al.. (2019). Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy. Nature Communications. 10(1). 4262–4262. 15 indexed citations
7.
Aoki, Masashi, Ryoichi Nakamura, Naoki Hayashi, et al.. (2019). [The Role of Patient Registry in the Care and Therapeutic Development for Patients with Amyotrophic Lateral Sclerosis: JaCALS].. PubMed. 71(11). 1215–1225.
8.
Kondo, Naohide, Genki Tohnai, Kentaro Sahashi, et al.. (2019). DNA methylation inhibitor attenuates polyglutamine‐induced neurodegeneration by regulating Hes5. EMBO Molecular Medicine. 11(5). 16 indexed citations
9.
Tanikawa, Chizu, Koji Ueda, Akari Suzuki, et al.. (2018). Citrullination of RGG Motifs in FET Proteins by PAD4 Regulates Protein Aggregation and ALS Susceptibility. Cell Reports. 22(6). 1473–1483. 77 indexed citations
10.
Nakamura, Takahiro J., et al.. (2017). Association of impaired melatonin secretion with sleep disturbance in Parkinson’s disease. Journal of the Neurological Sciences. 381. 296–296. 1 indexed citations
11.
Ding, Ying, Hiroaki Adachi, Masahisa Katsuno, et al.. (2016). BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1. Neuroscience. 327. 20–31. 14 indexed citations
12.
Sahashi, Kentaro, Masahisa Katsuno, Gene Hung, et al.. (2015). Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy. Human Molecular Genetics. 24(21). 5985–5994. 46 indexed citations
13.
Ding, Ying, Hiroaki Adachi, Masahisa Katsuno, et al.. (2015). Overexpression of hepatocyte growth factor in SBMA model mice has an additive effect on combination therapy with castration. Biochemical and Biophysical Research Communications. 468(4). 677–683. 5 indexed citations
14.
Tohnai, Genki, Hiroaki Adachi, Masahisa Katsuno, et al.. (2014). Paeoniflorin eliminates a mutant AR via NF-YA-dependent proteolysis in spinal and bulbar muscular atrophy. Human Molecular Genetics. 23(13). 3552–3565. 30 indexed citations
15.
Iida, Madoka, Masahisa Katsuno, Hideaki Nakatsuji, et al.. (2014). Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors. Human Molecular Genetics. 24(2). 314–329. 26 indexed citations
16.
Kondo, Naohide, Masahisa Katsuno, Hiroaki Adachi, et al.. (2013). Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration. Nature Communications. 4(1). 1405–1405. 44 indexed citations
17.
Qiang, Qiang, Hiroaki Adachi, Zhe Huang, et al.. (2013). Genistein, a natural product derived from soybeans, ameliorates polyglutamine‐mediated motor neuron disease. Journal of Neurochemistry. 126(1). 122–130. 11 indexed citations
18.
Doi, Hideki, Hiroaki Adachi, Masahisa Katsuno, et al.. (2013). p62/SQSTM1 Differentially Removes the Toxic Mutant Androgen Receptor via Autophagy and Inclusion Formation in a Spinal and Bulbar Muscular Atrophy Mouse Model. Journal of Neuroscience. 33(18). 7710–7727. 50 indexed citations
19.
Miyazaki, Yu, Hiroaki Adachi, Masahisa Katsuno, et al.. (2012). Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nature Medicine. 18(7). 1136–1141. 118 indexed citations
20.
Kawashima, Daisuke, et al.. (2010). Protective effect of a molecular chaperone inducer, paeoniflorin, on the HCl- and ethanol-triggered gastric mucosal injury. Life Sciences. 88(7-8). 350–357. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naohide Kondo Breakdown of academic impact, for papers by Ina Woods Breakdown of academic impact, for papers by Mariane da Cunha Jaeger Breakdown of academic impact, for papers by Yilu Gao Breakdown of academic impact, for papers by Laura Cajola Breakdown of academic impact, for papers by Francesco P. Jori Breakdown of academic impact, for papers by A. Harel Breakdown of academic impact, for papers by Amanda M. Smith Breakdown of academic impact, for papers by Lindsey D. Goodman Breakdown of academic impact, for papers by Maria Dimitriadi
Rankless by CCL
2026